Ago tumor Fundamentals Explained
Founded immune markers still maintain their relevance for clinical choice-creating in breast cancer treatment method with even extended meanings. Estrogen receptor (ER) stage must not only be classified in beneficial or negative. Very low ER amounts ≤ten% of labeled cells should be taken care of otherwise (LoE 1a/A/Back++). Tumors with reduced ER